Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

1 min read

Selexis to Partner and Exhibit at BIO 2013

Apr 10, 2013 2:26:18 PM

Selexis to Meet with Companies Interested in Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing

Geneva, Switzerland (PRWEB) April 10, 2013 – Selexis SA, a global life sciences company for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins, announced today today representatives from the Company will be participating in the BIO International Convention’s One-on-One Partnering Meetings being held April 22 – 25, 2013 at McCormick Place in Chicago, IL.

Selexis has partnerships and commercial deals with leading biotechnology and pharmaceutical companies worldwide. Selexis’ SUREtechnology Platform™ allows for faster and more reliable cell line development with higher expression levels which can be applied to a wide range of areas such as bio-manufacturing, drug discovery, diagnostics, and therapeutics.

Representatives will be available to discuss Selexis’ capabilities. Companies or individuals attending BIO 2013 can schedule meetings with Selexis by visiting (registration required):

Selexis Business Forum Partnering Schedule:

Monday, April 22 Business Forum - 08:00 AM – 05:00 PM
Tuesday, April 23 Business Forum - 08:00 AM – 05:00 PM
Wednesday, April 24 Business Forum - 08:00 AM – 05:00 PM
Thursday, April 25 Business Forum - 08:00 AM – 12:00 PM

For companies or individuals not participating in partnering meetings, Selexis will be exhibiting in booth number #4158 located in Hall C

Selexis Exhibit Hall Schedule and Partnering:

Monday, April 22 Hall C - 12:00 PM – 05:00 PM
Tuesday, April 23 Hall C - 10:00 AM – 05:00 PM
Wednesday, April 24 Hall C - 10:00 AM – 05:00 PM
Thursday, April 25 Hall C - 10:00 AM – 12:00 PM

Topics: 2013